Covered recipient · General Payments record
ALLISON M LAWRENCE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$1,381.50
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $148.44 | 17 |
| Food and Beverage | $31.33 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $148.44 | 17 |
| Corium, Inc. | $31.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $31.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100073689 | CMS |
| Vanda Pharmaceuticals Inc. | $1.20 | 10/01/2024 | Education | Undisputed | 01/23/2026 | 1133953636 | CMS |
| Vanda Pharmaceuticals Inc. | $1.20 | 10/15/2024 | Education | Undisputed | 01/23/2026 | 1133953638 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1133953640 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1133953642 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1133953644 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1133953646 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1133953648 | CMS |
| Vanda Pharmaceuticals Inc. | $1.20 | 10/21/2024 | Education | Undisputed | 01/23/2026 | 1133953650 | CMS |
| Vanda Pharmaceuticals Inc. | $1.20 | 10/28/2024 | Education | Undisputed | 01/23/2026 | 1133953652 | CMS |
| Vanda Pharmaceuticals Inc. | $1.20 | 11/08/2024 | Education | Undisputed | 01/23/2026 | 1133953654 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 11/15/2024 | Education | Undisputed | 01/23/2026 | 1133953656 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 11/15/2024 | Education | Undisputed | 01/23/2026 | 1133953658 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 11/15/2024 | Education | Undisputed | 01/23/2026 | 1133953660 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 12/16/2024 | Education | Undisputed | 01/23/2026 | 1133953662 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 12/16/2024 | Education | Undisputed | 01/23/2026 | 1133953664 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 12/16/2024 | Education | Undisputed | 01/23/2026 | 1133953666 | CMS |
| Vanda Pharmaceuticals Inc. | $11.87 | 12/16/2024 | Education | Undisputed | 01/23/2026 | 1133953668 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.